Simon Rule
MD, FRCP, FRCPath
Professor of Clinical Haematology
👥Biography 个人简介
Simon Rule is a leading international authority on mantle cell lymphoma and pioneered the use of ibrutinib in relapsed/refractory MCL. He led key phase II studies that supported ibrutinib approval in MCL. His work spans MCL biology, novel targeted agents, and treatment sequencing. He serves on multiple international lymphoma guideline committees.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Simon Rule 的研究动态
Follow Simon Rule's research updates
留下邮箱，当我们发布与 Simon Rule（University of Plymouth / Derriford Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment